Vitamin Toxicity Workup
- Author: Mark Rosenbloom, MD, MBA; Chief Editor: Asim Tarabar, MD more...
Acetaminophen and aspirin levels should be assessed in every suspected ingestion. Electrolyte levels must be assessed in patients with severe vomiting or diarrhea.
In addition to laboratory studies, imaging and electrocardiographic studies can be used in the assessment of patients with vitamin toxicity.
Imaging studies can be employed as follows:
Skeletal radiography - For calcifications in chronic vitamin A and vitamin D toxicity
Hand radiography - For periosteal calcifications
Helical computed tomography (CT) scanning and urography - Obtain a helical CT scan or an intravenous urogram (IVU) for suspected nephrolithiasis (ie, oxalate stones) in patients with vitamin C toxicity
CT scanning of the brain - In the presence of neurologic abnormalities, perform a CT scan of the brain, without contrast, only if the prothrombin time (PT) is significantly prolonged and the patient has either a decreased level of consciousness or a focal neurologic deficit
Kidneys, ureters, bladder (KUB) film - Indicated for suspected toxicity from iron-containing pills
Bone mineral density testing - to evaluate the effect of long-term vitamin A intoxication on reducing bone density and causing osteoporosis 
Obtain an electrocardiogram (ECG) to evaluate for effects of hypercalcemia in patients with vitamin D toxicity.
The reference range for vitamin A is 20-60 mcg/dL, and a toxic level is higher than 60-100 mcg/dL. Obtain a complete blood count (CBC) to rule out leukopenia. Also perform calcium, glucose, and liver function tests (LFTs). levels are affected by liver stores and dietary intake of vitamin A.
For serum carotene, the normal range is 50-300 mcg/dL. Carotene levels reflects dietary intake of vitamin A.
Laboratory studies in vitamin A toxicity include the following:
Serum electrolytes - If vomiting or diarrhea is present
Serum calcium - Hypercalcemia may be observed 
Liver function tests (LFTs)
Complete blood count (CBC) - For anemia, leukopenia, or thrombocytopenia
Vitamin A assessment by serum retinol concentrations - Vitamin A assessment by serum retinol concentrations may be helpful if the level is markedly high; in mild conditions, however, it may not be sensitive
High-performance liquid chromatography (HPLC)
Johnson-Davis et al reported that a modified form of HPLC they developed shortened analysis time for serum concentrations of vitamins A and E. Using their modifications—a high-throughput analytic column and small diameter tubing—to determine pediatric reference intervals for the 2 vitamins in 1136 healthy children, the authors found that their technique reduced run-time by 60%, mobile phase consumption by 39%, and sample injection volume by 50%.
A lumbar puncture may be indicated to rule out increased intracranial pressure in patients with vitamin A toxicity.
Vitamins B-1, B-2, and B-12
These require no specific laboratory tests for these vitamins.
Perform LFTs. Uric acid may be increased, leading to gouty arthritis. The glucose level is occasionally elevated.
Vitamin B-6 toxicity does not require laboratory or other tests. Lumbar puncture may be considered to rule out other causes if the patient has a peripheral neuropathy.
Perform urinalysis to rule out uricosuria. False-negative test results for glucosuria are possible. Also perform renal function tests.
Measure PT if the patient is taking warfarin (Coumadin), since vitamin C may interfere with this drug. Serum iron levels should also be measured, because vitamin C enhances iron absorption.
Obtaining calcium levels is mandatory; they are usually above 11 mg/dL but may be much higher. Phosphate levels may increase with calcium.
Renal function tests (ie, blood urea nitrogen [BUN] and creatine tests, as well as urinalysis) are necessary to rule out possible kidney damage from hypercalciuria.
Measure PT, activated partial thromboplastin time (aPTT), and bleeding times, especially if any evidence of bruising or bleeding is present. Platelet aggregation studies may be performed if bleeding time results are abnormal.
Monitor PT in patients who are taking anticoagulants concurrently with vitamin E or in patients suggested to have vitamin K deficiency while taking vitamin E, because the PT may be elevated.
The plasma concentration of alpha tocopherol (normal, 6-14 mcg/mL) can be measured to confirm that high levels of vitamin E are in the blood.
Measure PT if the patient is taking oral anticoagulants.
Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol (Phila). 2015 Dec. 53 (10):962-1147. [Medline]. [Full Text].
American Association of Poison Control Centers’ National Poison Data System. Annual Reports. Available at http://www.aapcc.org/annual-reports. Accessed: December 5, 2015.
North America, Asia lead vitamin and supplement usage. Nielsen Wire. Available at http://blog.nielsen.com/nielsenwire/consumer/north-america-asia-lead-vitamin-and-supplement-usage/. Accessed: December 5, 2015.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Multivitamin/mineral Supplements. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/MVMS-HealthProfessional/. July 8, 2015; Accessed: December 5, 2015.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin A. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/vitamina.asp. June 05, 2013; Accessed: December 5, 2015.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin B6. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/. September 15, 2011; Accessed: December 5, 2015.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin B12. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/. June 24, 2011; Accessed: December 5, 2015.
Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al. Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther. 2014 May 26. 13(4):280-300. [Medline].
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin C. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/. June 05, 2013; Accessed: December 5, 2015.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin D. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. November 10, 2014; Accessed: December 5, 2015.
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005 Jan 4. 142(1):37-46. [Medline]. [Full Text].
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012 Mar 14. 3:CD007176. [Medline].
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin E. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/. Accessed: October 13, 2014.
Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes (DRIs): Recommended Dietary Allowances and Adequate Intakes, Vitamins. Available at http://iom.edu/Activities/Nutrition/SummaryDRIs/~/media/Files/Activity%20Files/Nutrition/DRIs/RDA%20and%20AIs_Vitamin%20and%20Elements.pdf. Accessed: October 13, 2014.
Tan KP, Kosuge K, Yang M, Ito S. NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity. Free Radic Biol Med. 2008 Dec 15. 45(12):1663-73. [Medline].
Maqbool A, Stallings VA. Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med. 2008 Nov. 14(6):574-81. [Medline].
Mawson AR. On the association between low resting heart rate and chronic aggression: retinoid toxicity hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17. 33(2):205-13. [Medline].
Corrigan JJ Jr, Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA. 1974 Dec 2. 230(9):1300-1. [Medline].
Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001 Nov 29. 345(22):1583-92. [Medline]. [Full Text].
Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol. 2001 Aug. 21(8):1320-6. [Medline]. [Full Text].
Liu M, Wallin R, Wallmon A, Saldeen T. Mixed tocopherols have a stronger inhibitory effect on lipid peroxidation than alpha-tocopherol alone. J Cardiovasc Pharmacol. 2002 May. 39(5):714-21. [Medline].
Hathcock JN, Azzi A, Blumberg J, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. Apr 2005. 81(4):736-45.
Debreceni B, Debreceni L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?. Cardiovasc Ther. 2012 Aug. 30(4):227-33. [Medline].
Harling L, Rasoli S, Vecht JA, Ashrafian H, Kourliouros A, Athanasiou T. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials. Heart. 2011 Oct. 97(20):1636-42. [Medline].
Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003 Jun 14. 361(9374):2017-23. [Medline].
Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med. 2007 Aug 13-27. 167(15):1610-8. [Medline]. [Full Text].
Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12. 306(14):1549-56. [Medline].
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6. 360(9326):23-33. [Medline].
Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu W, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004 Apr. 19(4):380-9. [Medline]. [Full Text].
Orrell RW, Lane RJ, Ross M. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler. 2008 Aug. 9(4):195-211. [Medline].
Lane JS, Magno CP, Lane KT, Chan T, Hoyt DB, Greenfield S. Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg. 2008 Oct. 48(4):897-904. [Medline].
Mahabir S, Schendel K, Dong YQ, Barrera SL, Spitz MR, Forman MR. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int J Cancer. 2008 Sep 1. 123(5):1173-80. [Medline]. [Full Text].
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005 Mar 16. 293(11):1338-47. [Medline]. [Full Text].
Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004 Jul 26. 164(14):1552-6. [Medline].
Liede KE, Haukka JK, Saxén LM, Heinonen OP. Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid. Ann Med. 1998 Dec. 30(6):542-6. [Medline].
Leppälä JM, Virtamo J, Fogelholm R, Huttunen JK, Albanes D, Taylor PR, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol. 2000 Jan. 20(1):230-5. [Medline]. [Full Text].
Handelman GJ. High-dose vitamin supplements for cigarette smokers: caution is indicated. Nutr Rev. 1997 Oct. 55(10):369-70. [Medline].
Spiller HA, Good TF, Spiller NE, Aleguas A. Vitamin D exposures reported to US poison centers 2000-2014: Temporal trends and outcomes. Hum Exp Toxicol. 2015 Oct 30. [Medline].
Genaro Pde S, Martini LA. Vitamin A supplementation and risk of skeletal fracture. Nutr Rev. 2004 Feb. 62(2):65-7. [Medline].
Ribaya-Mercado JD, Blumberg JB. Vitamin A: is it a risk factor for osteoporosis and bone fracture?. Nutr Rev. 2007 Oct. 65(10):425-38. [Medline].
Miksad R, de Lédinghen V, McDougall C, Fiel I, Rosenberg H. Hepatic hydrothorax associated with vitamin a toxicity. J Clin Gastroenterol. 2002 Mar. 34(3):275-9. [Medline].
Barker ME, Blumsohn A. Is vitamin A consumption a risk factor for osteoporotic fracture?. Proc Nutr Soc. 2003 Nov. 62(4):845-50. [Medline].
Bhalla K, Ennis DM, Ennis ED. Hypercalcemia caused by iatrogenic hypervitaminosis A. J Am Diet Assoc. 2005 Jan. 105(1):119-21. [Medline].
Johnson-Davis KL, Moore SJ, Owen WE, Cutler JM, Frank EL. A rapid HPLC method used to establish pediatric reference intervals for vitamins A and E. Clin Chim Acta. 2009 Jul. 405(1-2):35-8. [Medline].